Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Preoperative and Post Operative Misoprostol Administration on Intraoperative Blood Loss and Postpartum Hemorrhage in CS

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~women attending for elective CS.~* Age between 20-35 years.~* Normal placental site~* Normal coagulation profile~* Full term pregnancies(above 37 wks)~* Medically free~* Spinal anesthesia~* Living baby~* Average liquor by U/S~Exclusion Criteria:~* • Women attending for emergency CS~  * .age below 20 or above 35~ * Abnormal placentation (Placenta previa,accrete,increta or percreta)~ * Women with coagulopathy~ * Preterm pregnancies (before 37 wks)~ * Medical disorder (Hypertension,Diabetes, Endocrinal disorder)~ * General anathesia~ * IUFD~ * Oligo or polyhydraminos by U/S

- Gender: FEMALE
- Minimum Age: 20 Years
- Maximum Age: 35 Years
- Healthy Volunteers: f

Study Arms:
- Routine ecbolic group (Type: ACTIVE_COMPARATOR): 100 patients will receive routine ecbolics ( oxytocin) after delivery of baby
- Misoprostol group (Type: ACTIVE_COMPARATOR): The 100 patients will receive routine ecbolics (oxytocin) after delivery of baby plus 400 microgram misoprostol rectally with catheterization and another 400 microgram rectally after closure of abdomen

Based on this trial design, predict the completion outcome and termination type (if applicable).